184 related articles for article (PubMed ID: 16825385)
41. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
Fleece D; Gaughan JP; Aronoff SC
Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
[TBL] [Abstract][Full Text] [Related]
42. Species distribution and antifungal susceptibilities of dermatophytes during a one year period at a university hospital in Turkey.
Ozkutuk A; Ergon C; Yulug N
Mycoses; 2007 Mar; 50(2):125-9. PubMed ID: 17305776
[TBL] [Abstract][Full Text] [Related]
43. In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
Lortholary O; Dannaoui E; Raoux D; Hoinard D; Datry A; Paugam A; Poirot JL; Lacroix C; Dromer F;
Antimicrob Agents Chemother; 2007 Sep; 51(9):3378-80. PubMed ID: 17576839
[TBL] [Abstract][Full Text] [Related]
44. In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis.
Saunte DM; Simmel F; Frimodt-Moller N; Stolle LB; Svejgaard EL; Haedersdal M; Kloft C; Arendrup MC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3317-21. PubMed ID: 17576826
[TBL] [Abstract][Full Text] [Related]
45. Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis.
Gupta AK; Cooper EA; Bowen JE
J Drugs Dermatol; 2008 Apr; 7(4):369-72. PubMed ID: 18459518
[TBL] [Abstract][Full Text] [Related]
46. The assessment and management of tinea capitis in children.
Ali S; Graham TA; Forgie SE
Pediatr Emerg Care; 2007 Sep; 23(9):662-5; quiz 666-8. PubMed ID: 17876261
[TBL] [Abstract][Full Text] [Related]
47. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Seifert H; Aurbach U; Stefanik D; Cornely O
Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
[TBL] [Abstract][Full Text] [Related]
48. EUCAST Technical Note on voriconazole.
Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing
Clin Microbiol Infect; 2008 Oct; 14(10):985-7. PubMed ID: 18828859
[No Abstract] [Full Text] [Related]
49. Does one voriconazole breakpoint suit all Candida species?
Arendrup MC; Denning DW; Pfaller MA; Diekema DJ; Rex JH
J Clin Microbiol; 2007 Jun; 45(6):2093; author reply 2094. PubMed ID: 17548458
[No Abstract] [Full Text] [Related]
50. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
Santos DA; Hamdan JS
Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrum.
Deng S; Zhang C; Seyedmousavi S; Zhu S; Tan X; Wen Y; Huang X; Lei W; Zhou Z; Fang W; Shen S; Deng D; Pan W; Liao W
Antimicrob Agents Chemother; 2015 Jul; 59(7):4312-4. PubMed ID: 25896691
[TBL] [Abstract][Full Text] [Related]
52. Tinea capitis in infants in their first year of life.
Gilaberte Y; Rezusta A; Gil J; Sáenz-Santamaría MC; Coscojuela C; Navarro M; Zubiri ML; Moles B; Rubio MC
Br J Dermatol; 2004 Oct; 151(4):886-90. PubMed ID: 15491432
[TBL] [Abstract][Full Text] [Related]
53. Tinea capitis due to Trichophyton rubrum in a 3-month-old infant.
Valari M; Stefanaki C; Karteri G; Zarkadi E; Katsambas A
Mycoses; 2006 Sep; 49(5):439-40. PubMed ID: 16922801
[TBL] [Abstract][Full Text] [Related]
54. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.
Krishnan-Natesan S; Chandrasekar PH; Alangaden GJ; Manavathu EK
Int J Antimicrob Agents; 2008 Dec; 32(6):519-24. PubMed ID: 18775650
[TBL] [Abstract][Full Text] [Related]
55. Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals.
Arredondo-García JL; Amábile-Cuevas CF;
J Infect Dev Ctries; 2009 Jun; 3(5):398-401. PubMed ID: 19759511
[TBL] [Abstract][Full Text] [Related]
56. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):273-6. PubMed ID: 17141455
[TBL] [Abstract][Full Text] [Related]
57. [Comparative studies of the resistance of dermatophytes against antimycotic antibiotics].
Balabanoff VA; Usunov P
Mykosen; 1970 Nov; 13(11):531-6. PubMed ID: 5486012
[No Abstract] [Full Text] [Related]
58. [How to cope with tinea capitis?].
Lateur N
Rev Med Brux; 2004 Jun; 25(3):148-52. PubMed ID: 15291446
[TBL] [Abstract][Full Text] [Related]
59. [Comparative studies of dermatophyte resistance to antifungal antibiotics. II. Morphological changes].
Usunov P; Balabanoff VA
Mykosen; 1974 Mar; 17(3):45-56. PubMed ID: 4839501
[No Abstract] [Full Text] [Related]
60. [Use of the replica method for determining dermatophyte sensitivity and resistance to griseofulvin].
Vasil'ev OD
Vestn Dermatol Venerol; 1978 Aug; (8):22-5. PubMed ID: 695909
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
